webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz

  CAS No.: 2914227-56-6   Cat No.: BADC-01801 4.5  

Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz is a peptide-PEG based ADC linker intermediate incorporating Gly-Gly-Phe-Gly sequence and PEG4 spacer, designed for enzyme-cleavable payload release in antibody-drug conjugates. Keywords: ADC linker, peptide linker, PEG spacer, enzyme-cleavable, controlled release.

Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz

Structure of 2914227-56-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C51H62N6O14
Molecular Weight
983.07

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
benzyl 2-[[[2-[[(2S)-2-[[2-[[2-[3-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]methoxy]acetate
Canonical SMILES
C1=CC=C(C=C1)CC(C(=O)NCC(=O)NCOCC(=O)OCC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)CCOCCOCCOCCOCCNC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35
InChI
InChI=1S/C51H62N6O14/c58-45(19-21-65-23-25-67-27-28-68-26-24-66-22-20-52-51(64)71-34-43-41-17-9-7-15-39(41)40-16-8-10-18-42(40)43)53-30-46(59)54-32-48(61)57-44(29-37-11-3-1-4-12-37)50(63)55-31-47(60)56-36-69-35-49(62)70-33-38-13-5-2-6-14-38/h1-18,43-44H,19-36H2,(H,52,64)(H,53,58)(H,54,59)(H,55,63)(H,56,60)(H,57,61)/t44-/m0/s1
InChIKey
XWNKFXDCWVHQPN-SJARJILFSA-N

Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz, a versatile biochemical reagent, finds wide applications in peptide synthesis and drug delivery systems. Here are four key applications:

Peptide Synthesis: Playing a pivotal role in solid-phase peptide synthesis, Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz aids in crafting intricate peptide chains. The Fmoc group acts as a protective shield for the amino terminus, ensuring seamless synthesis. This reagent facilitates the meticulous assembly of peptides, guaranteeing high purity and yield in the final products.

Drug Delivery Systems: Delving into the realm of drug delivery systems, this reagent features prominently in optimizing the solubility and stability of therapeutic agents. The PEG spacer injects hydrophilicity, enhancing the bioavailability of hydrophobic drugs. Featuring a GGFG sequence as a cleavable linker, it artfully unveils the active drug under specific physiological conditions, maximizing therapeutic potential.

Protein Conjugation: In the protein conjugation, Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz steps in to amplify the functionality and therapeutic efficacy of proteins. The PEG spacer acts as a shield against immunogenicity and prolongs the half-life of therapeutic proteins. Conjugating with this reagent promises enhanced pharmacokinetic and pharmacodynamic profiles.

Bioconjugate Chemistry: Diving into bioconjugate chemistry, this reagent offers a gateway to meld various biomolecules like antibodies, enzymes, and nucleic acids with targeting moieties or functional groups. PEGylation, a key feature, mitigates steric hindrance and bolsters overall stability. These bioconjugates facilitate targeted drug delivery and molecular imaging.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: t-Boc-N-amido-PEG1-propionic acid | t-Boc-N-amido-PEG2-bromide | t-Boc-N-amido-PEG4-propionic acid | t-Boc-N-amido-PEG4-bromide | t-Boc-N-amido-PEG4-amine | t-Boc-N-amido-PEG6-alcohol | t-Boc-N-amido-PEG9-alcohol | Fmoc-PEG4-GGFG-CH2-O-CH2-Cbz
Send Inquiry
Verification code
Inquiry Basket